Gregory E Conner

age ~74

from Miami, FL

Get Report

Also known as:

Gregory Dr Conner
Gregory Edward Conner
Gregory F Conner
Gregory Edward Conner Trs
Gregory E Connor

Phone and address:: 1780 Micanopy Ave, Miami, FL 33133
3058568420

Connected to:

Gregory Conner Phones & Addresses

1780 Micanopy Ave, Miami, FL 33133 • 3058568420
Jacksonville, FL

Resumes

Associate Professor

view source

Location:

Miami, FL

Industry:

Research

Work:

University of Miami
Associate Professor

Gregory Conner

view source

Gregory Conner

view source

Location:

Cary, North Carolina

Industry:

Computer Hardware

Name / Title

Company / Classification

Phones & Addresses

Gregory H. Conner
President

Society of Financial Service Professionals Southeast Florida Chapter, Inc

8930 W State Rd 84, Fort Lauderdale, FL 33324
3452 Pierce St, Hollywood, FL 33021

Gregory M. Conner
Director, Vice President

Stamm & Russo, Inc

5100 N Federal Hwy, Fort Lauderdale, FL 33308

Gregory M. Conner
President, Vice President

Newmarket, Inc

5100 N Federal Hwy, Fort Lauderdale, FL 33308

Gregory H Conner
Manager

GTF HOLDINGS, LLC

999 Brickell Ave SUITE 401, Miami, FL 33131

Gregory M. Conner
Treasurer, Director, Secretary

Wilcox Marine, Inc

262 SW 33 St, Fort Lauderdale, FL 33315
268 SW 33 St, Fort Lauderdale, FL 33315

Us Patents

Methods And Devices For Treating Lung Dysfunction
view source
US Patent:

7770577, Aug 10, 2010
Filed:

Feb 3, 2004
Appl. No.:

10/771057
Inventors:

Gregory E Conner - Miami FL, US
International Classification:

A61M 11/00
A61K 33/40
A61K 31/075
US Classification:

12820014, 424616, 514714
Abstract:

Methods and devices useful for treatment of lung conditions resulting from dysfunction of normal pulmonary physiology.

Novel Methods And Devices For Treating Lung Dysfunction
view source
US Patent:

20020172645, Nov 21, 2002
Filed:

May 14, 2002
Appl. No.:

10/146405
Inventors:

Gregory Conner - Miami FL, US
International Classification:

A61L009/04
US Classification:

424/045000
Abstract:

Methods and devices useful for treatment of lung conditions resulting from dysfunction of normal pulmonary physiology.

Treatment Of Respiratory Conditions Associated With Bronchoconstriction With Aerosolized Hyaluronic Acid
view source
US Patent:

20030171332, Sep 11, 2003
Filed:

Jun 17, 2002
Appl. No.:

10/174221
Inventors:

William Abraham - Miami FL, US
Mario Scuri - Miami FL, US
Rosanna Forteza - Miami FL, US
Jing-Wen Kuo - Wakefield MA, US
Paul Mihalko - Fremont CA, US
Gregory Conner - Miami FL, US
Matthias Salathe - Coral Gables FL, US
International Classification:

A61K031/737
A61K031/728
A61K031/727
A61L009/04
US Classification:

514/054000, 514/056000, 424/045000
Abstract:

A method is disclosed for treating and/or preventing bronchoconstriction induced by neutrophil elastase and tissue kallikrein activity. The method includes administration of aerosolized hyaluronic acid in an amount sufficient to bind to RHAMM (CD168) receptors along the apical surface of the airway epithelium, wherein the hyaluronic acid binds and retains secreted tissue kallikrein, thereby treating and/or preventing bronchoconstriction due to kallikrein activity.

Methods And Devices For Treating Lung Dysfunction
view source
US Patent:

20100330061, Dec 30, 2010
Filed:

Jul 2, 2010
Appl. No.:

12/829881
Inventors:

Gregory E. Conner - Miami FL, US
International Classification:

A61K 38/44
A61K 33/40
A61K 38/43
A61P 31/04
A61P 11/00
A61P 31/10
A61P 31/12
US Classification:

424 944, 424616, 424 941
Abstract:

Methods and devices useful for treatment of lung conditions resulting from dysfunction of normal pulmonary physiology.